Andera Partners | Finanzwire

Basculer en Français

9472	Companies
185369	Keywords
117719	Articles
99261	Press releases

Home
Companies
Andera Partners

BRIEF

published on 10/22/2025 at 09:05, 1 month 13 days ago

Ipsen Acquires ImCheck Therapeutics to Strengthen Oncology Portfolio

Biotechnology Oncology Immunotherapy Mergers & Acquisitions AML
PRESS RELEASE

published on 10/22/2025 at 09:00, 1 month 13 days ago

Ipsen to acquire ImCheck Therapeutics, in Andera Partners’ portfolio, expanding its leadership in oncology, strengthening its pipeline
Ipsen to acquire ImCheck Therapeutics, expanding its leadership in oncology by acquiring all shares of ImCheck. Anticipated acquisition focuses on ICT01 program for acute myeloid leukemia. Transaction details and advisors highlighted

Acquisition Oncology Ipsen ImCheck Therapeutics ICT01
BRIEF

published on 10/16/2025 at 11:10, 1 month 19 days ago

Andera Partners Co-Leads €105 Million Series A for Adcytherix

Investment Andera Partners Cancer Treatments Adcytherix BioDiscovery 7
PRESS RELEASE

published on 10/16/2025 at 11:05, 1 month 19 days ago

Andera Partners co-leads €105 million Series A round for Adcytherix, its first investment from the BioDiscovery 7 fund
Andera Partners co-leads €105 million Series A funding round for Adcytherix, marking the first investment from BioDiscovery 7 fund to advance novel ADC programs for cancer treatment

Andera Partners ADC Series A Adcytherix BioDiscovery 7
BRIEF

published on 10/15/2025 at 11:15, 1 month 20 days ago

Andera Partners Commits to Tubulis' €308 Million Series C for ADC Development

Series C Financing Andera Partners Tubulis ADC Development Clinical Expansion
PRESS RELEASE

published on 10/15/2025 at 11:10, 1 month 20 days ago

Andera Partners Reinvests in Tubulis’ €308 million Series C to Accelerate Clinical Development of Lead ADC Candidate TUB-040 and Expand Pipeline
Andera Partners reinvests in Tubulis' €308 million Series C financing to accelerate clinical development of lead ADC candidate TUB-040 and expand pipeline, attracting top-tier investors

Series C Financing Clinical Development Andera Partners Tubulis ADC Candidate
BRIEF

published on 06/12/2025 at 10:05, 5 months 22 days ago

Andera Partners Expands Mezzanine Sponsorless Strategy with Key Appointments

Andera Partners Strategic Appointments European Markets International Development Mezzanine Sponsorless
PRESS RELEASE

published on 06/12/2025 at 10:00, 5 months 22 days ago

Andera Partners increases international development of its Mezzanine Sponsorless business and announces two strategic appointments
Andera Partners expands Mezzanine Sponsorless business internationally with two strategic appointments, reinforcing European private financing strategy

Andera Partners Strategic Appointments International Development Mezzanine Sponsorless Private Financing
BRIEF

published on 02/20/2025 at 08:10, 9 months 12 days ago

Andera Partners and Bpifrance Lead €27 Million Series B for EG 427

Series B Funding Genetic Medicine EG 427 Neuro-Urology HERMES Technology
PRESS RELEASE

published on 02/20/2025 at 08:05, 9 months 12 days ago

Andera Partners and Bpifrance co-lead €27 million Series B round for EG 427 to finance ongoing clinical study and platform development
Andera Partners and Bpifrance co-lead €27 million Series B round for EG 427 to finance ongoing clinical study and platform development in the field of neuro-urology. Proceeds will advance genetic medicine solutions using HERMES vector technology

Series B Andera Partners Bpifrance EG 427 Neuro-Urology

1 2 ... 4

Accesswire

Published on 12/05/2025 at 02:35, 3 hours 24 minutes ago

Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 02:30, 3 hours 29 minutes ago

Klondike Gold Announces AGM Results
Published on 12/05/2025 at 01:00, 4 hours 59 minutes ago

BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 6 hours 54 minutes ago

BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 6 hours 59 minutes ago

NXT Energy Solutions Completes Data Acquisition for SFD Survey

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 03:30, 2 hours 28 minutes ago

CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 6 hours 8 minutes ago

EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 9 hours 33 minutes ago

Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 9 hours 43 minutes ago

Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 10 hours 48 minutes ago

SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance

Les Echos

Published on 12/04/2025 at 18:00, 11 hours 59 minutes ago

Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 12 hours 14 minutes ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 12 hours 14 minutes ago

Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 22 hours 58 minutes ago

bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 11 hours ago

Declaration of voting rights at the end of November 2025

View all LES ECHOS COMFI WIRE